UBS Reiterates 3i Group (TGOPF) Buy Recommendation

UBS reiterated a "Buy" recommendation for 3i Group (TGOPF), setting an average one-year price target of $62.83, which implies a 66.05% upside from its current $37.84 share price. This positive analyst sentiment is notable given projected annual revenue is expected to decrease by 40.48% to 3,063MM, alongside a non-GAAP EPS of 2.42. Institutional interest in 3i Group remains robust, with 444 funds reporting positions and total institutional share ownership increasing by 1.91% in the last quarter, signaling continued investor confidence despite mixed financial projections.

Analysis

UBS has reiterated a "Buy" recommendation for 3i Group (OTCPK:TGOPF) on November 7, 2025, setting an average one-year price target of $62.83 per share. This target implies a significant 66.05% upside from the latest closing price of $37.84, suggesting strong analyst conviction in the company's future performance. The forecast range spans from $48.85 to $72.85, indicating a broad spectrum of potential outcomes.

Despite the bullish analyst outlook, 3i Group faces a projected annual revenue decrease of 40.48% to 3,063MM, alongside a non-GAAP EPS forecast of 2.42. This substantial revenue contraction presents a notable divergence from the positive price target, indicating potential underlying factors or a re-evaluation of the company's business model not fully detailed within the article. The overall sentiment for the company is labeled as mixed, reflecting this dichotomy.

Institutional interest in 3i Group remains robust, with 444 funds reporting positions, an increase of 1.14% in owners over the last quarter. Total shares owned by institutions rose by 1.91% to 217,830K shares in the last three months, and the average portfolio weight increased by 1.54%. However, individual fund movements are varied, with some major holders like AEPGX decreasing their stake by 11.45% while others like ANWPX significantly increased their holdings by 63.34%.

Key Decisions for Investors

• Investors should carefully evaluate the significant projected revenue decline of 40.48% against UBS's reiterated "Buy" rating and 66.05% price target upside, seeking clarity on the drivers of this divergence.
• Monitor future disclosures for explanations regarding the substantial revenue contraction and its potential impact on the company's long-term growth trajectory and valuation.
• Observe institutional positioning trends, noting both the overall increase in ownership and the mixed individual fund activity, to gauge evolving market sentiment and conviction among large investors.